[An immunoenzyme test system for the diagnosis of human larval paragonimiasis].
Human larval paragonimiasis, a special form, was identified in the Maritime Territory. A procedure for enzyme immunoassay was developed to diagnose this form of the disease, which showed 97% sensitivity and 92% specificity. The method has been employed in seroepidemiological screening of 2000 people in the Ussuri region. The presence of antibodies to Paragonimus antigens has been confirmed by RIHA and CFT for 26 out of 72 seropositive cases.